Degree Name
MA (Master of Arts)
Program
Kinesiology and Sport Studies
Date of Award
12-2003
Committee Chair or Co-Chairs
Diego de Hoyos
Committee Members
Diana Mozen, Kevin Breuel
Abstract
Recent evidence suggests that declining bone mineral density (BMD) in males is related to declining circulating estrogens. The majority of endogenous plasma estrogens in males result from peripheral aromatization of plasma androgens. Thus, it was hypothesized that dietary supplementation with an aromatizable androgen (androstenedione) may stimulate increases in BMD.
BMD (measured by dual energy x-ray absorptiometry) and biochemical markers of bone turnover (1, 25 OH2 Vitamin D, calcitonin, deoxypyrodinoline, and parathyroid hormone) were assessed before and after 12 weeks of dietary androstenedione supplementation (200 mg/d). Twenty-four volunteers were randomized into either an androstenedione supplementation or placebo groups. Study volunteers also performed high intensity resistance training (RT) during the treatment period.
Androstenedione supplementation significantly increased plasma estradiol-17β levels by 82%. However, the increase in estradiol-17β did not impact bone turnover. The RT regimen did stimulate significant, local increases in BMD. Spine BMD was significantly increased by 6% for both treatment groups.
Document Type
Thesis - unrestricted
Recommended Citation
Wills, Troy Matthew, "The Osteogenic Effects of 12 Weeks of Oral Supplementation of Androstenedione in Middle-Aged Men." (2003). Electronic Theses and Dissertations. Paper 829. https://dc.etsu.edu/etd/829
Copyright
Copyright by the authors.